Comment on 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.
作者信息
Ciccarese Giulia, Broccolo Francesco, Parodi Aurora, Drago Francesco
机构信息
Dermatology Unit, Policlinico San Martino, Genoa, Italy.
Department of Medicine and Surgery, School of Medicine, University of Milano-Bicocca, Monza, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e37-e38. doi: 10.1111/jdv.18498. Epub 2022 Aug 25.
Abstract
摘要
相似文献
1
Comment on 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.关于“玫瑰糠疹样皮疹中刺突蛋白免疫组化阳性患者的新冠病毒抗体阴性”的评论
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e37-e38. doi: 10.1111/jdv.18498. Epub 2022 Aug 25.
2
Authors' reply to comment by Ciccarese et al. regarding 'Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions'.作者对Ciccarese等人就“玫瑰糠疹样皮疹中刺突蛋白免疫组化呈阳性的患者中SARS-CoV-2抗体阴性”的评论的回复。
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e39-e40. doi: 10.1111/jdv.18546. Epub 2022 Sep 2.
3
Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptions.玫瑰糠疹样皮疹中刺突蛋白免疫组化呈阳性的患者SARS-CoV-2抗体为阴性。
J Eur Acad Dermatol Venereol. 2022 Sep;36(9):e661-e662. doi: 10.1111/jdv.18186. Epub 2022 May 6.
4
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.新冠病毒玫瑰糠疹样和荨麻疹样皮疹中严重急性呼吸综合征冠状病毒2刺突蛋白阳性
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
5
Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.COVID-19 及 COVID-19 疫苗接种背景下的玫瑰糠疹、玫瑰糠疹样发疹和带状疱疹。
Clin Dermatol. 2022 Sep-Oct;40(5):586-590. doi: 10.1016/j.clindermatol.2022.01.002. Epub 2022 Jan 31.
6
Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.玫瑰糠疹样皮疹：科兴新冠疫苗的一种皮肤表现。
Dermatol Ther. 2022 Feb;35(2):e15256. doi: 10.1111/dth.15256. Epub 2021 Dec 26.
7
Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.对西卡雷塞·G等人所著《玫瑰糠疹及新型冠状病毒肺炎疫苗接种后玫瑰糠疹样皮疹的临床、组织病理学和病毒学特征研究的意义》的回复
Dermatol Ther. 2022 Aug;35(8):e15602. doi: 10.1111/dth.15602. Epub 2022 Jun 13.
8
Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.玫瑰糠疹样疹与 COVID-19 mRNA-1273 疫苗接种的关系：病例报告及文献复习。
J Formos Med Assoc. 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. Epub 2022 Jan 5.
9
Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.玫瑰糠疹与 COVID-19 疫苗接种相关：新型疫苗接种后常见的皮疹。
Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411.
10
The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.研究玫瑰糠疹及新冠病毒疫苗接种后玫瑰糠疹样皮疹的临床、组织病理学和病毒学特征的意义。
Dermatol Ther. 2022 Aug;35(8):e15601. doi: 10.1111/dth.15601. Epub 2022 Jun 13.
Zotero 插件